MedPath

Fish Oil Supplements for Recovery after Mild Traumatic Brain Injury (mTBI): A Randomised Control Trial

Not Applicable
Conditions
Mild Traumatic Brain Injury
Injuries and Accidents - Other injuries and accidents
Neurological - Other neurological disorders
Registration Number
ACTRN12617000040369
Lead Sponsor
Massey University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Stopped early
Sex
All
Target Recruitment
12
Inclusion Criteria

Individuals who have suffered a mTBI and are experiencing difficulty with one or more of the following cognitive domains will be eligible for inclusion: memory, attention, concentration, processing speed, and/or executive function. Participants must also be fluent in the English language, have access to a telephone and a distraction free environment for one hour every three months, and be able to hear clearly over the telephone.

Exclusion Criteria

Individuals who are already taking fish oil, have taken fish oil in the last 6 months, or consume more than 3 servings of oily fish per week will be excluded. Anyone who has had recent surgery or is suffering from significant peripheral injury, is taking medication that affects cognitive function, or has any mental or neurological disorder that affects cognition will not be eligible to participate. Additionally, those with seafood allergy, aversion to fish/beef gelatin, difficulty swallowing capsules, or women who are pregnant or breastfeeding will be ineligible.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change in over all cognitive symptoms, measured using a composite score derived from the following cognitive subtests: Logical memory, digit span forward and backward, verbal fluency, paced auditory serial addition test, and backwards counting. All tests are administered via telephone.[Baseline - before intervention, three months after beginning the intervention, completion - six months after beginning the intervention.]
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath